Source: Annual Congress 2010 - Causal factors and mechanisms of outdoor air pollution and nanoparticulates
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Dagher, J. Peluso, C. D. Muller, G. Ubeaud-Séquier (Fanar, Lebanon; Strasbourg, France). Molecular epidemiology of adverse respiratory effects: A high-throughput screening method to detect biomarkers of genotoxic exposure. Eur Respir J 2010; 36: Suppl. 54, 434

Member's Comments

No comment yet.

Related content which might interest you: Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Applying clinical metagenomics for the detection and characterisation of respiratory infections Source: Eur Respir Monogr 2019; 83: 35-49 Year: 2019 Modern molecular direct tests for rapid identification and drug susceptibility testing of Mycobacterium tuberculosis Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012 Imaging and molecular biomarkers: a novel approach to screen populations at risk of pulmonary fibrosis? Source: Eur Respir J 2016; 48: 1271-1273 Year: 2016 Genetic studies as a tool for identifying novel potential targets for treatment of COPD Source: Eur Respir J, 50 (5) 1702042; 10.1183/13993003.02042-2017 Year: 2017 Molecular markers involved in susceptibility to lung injury after acute exposure to tobacco smoke in different mouse strains. Fluorescent molecular in vivo imaging application Source: Annual Congress 2011 - Recent developments in COPD Year: 2011 Are epigenetic and transcriptomic signatures of air pollution exposure valid biomarkers? Source: ERS Research Seminar 2017 – The impact of air pollution on respiratory health Year: 2018 A combinational approach to optimize biomarkers efficacy in identifying patients with sarcoidosis and monitoring respiratory functional worsening Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV Year: 2012 Monitoring asthma: state-of-the-art physiological, imaging, and biomarker assessments Source: International Congress 2016 – PG1 Asthma and chronic obstructive pulmonary disease Year: 2016 Monitoring asthma – state-of-the-art physiological, imaging, and biomarker assessments Source: International Congress 2015 – PG2 Asthma and COPD Year: 2015 Novel biomarker more strongly associated with tuberculosis treatment outcome than conventional or genotypic methods Source: International Congress 2015 – Science and biomarkers in TB Year: 2015 Effectiveness of different biomarkers in assessing asphalt exposure health effects Source: Eur Respir J 2006; 28: Suppl. 50, 619s Year: 2006 High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications Source: Eur Respir J 2009; 33: 489-506 Year: 2009 Monitoring asthma - state-of-the-art physiological, imaging and biomarker assessments Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease Year: 2018 Assessing the impact of workers' prior experience of lung function testing and potential effects on future testing Source: International Congress 2019 – Environment, work and respiratory health in occupational and environmental lung diseases Year: 2019 Predictors of patterns of response following specific inhalation challenge testing with low molecular weight agents. Source: International Congress 2018 – Occupational and environmental lung diseases: asthma and the airways Year: 2018 The use of toxicogenomics to identify biomarkers of exposure in an airway epithelium model exposed to tobacco smoke components Source: Eur Respir J 2006; 28: Suppl. 50, 825s Year: 2006